RPS15 and cancer: Of note, these authors demonstrated that expression of mutant RPS15 revealed defective regulation of endogenous p53 (with reduced stabilization and increased p53 degradation) compared with wild-type RPS15. Both MLL2 and EP300 have been identified as significantly mutated across cancers with known roles in histone and chromatin regulation, respectively.